ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	49/487	191/7206	7.16847634009e-17
ko04621	NOD-like receptor signaling pathway	43/487	157/7206	4.77113674838e-16
ko05164	Influenza A	41/487	167/7206	1.40133308918e-13
ko04380	Osteoclast differentiation	36/487	134/7206	2.46467390596e-13
ko04650	Natural killer cell mediated cytotoxicity	29/487	97/7206	3.01052917539e-12
ko04217	Necroptosis	40/487	178/7206	6.0427491937e-12
ko05162	Measles	32/487	120/7206	6.85842588455e-12
ko04064	NF-kappa B signaling pathway	28/487	96/7206	1.4034901471e-11
ko05340	Primary immunodeficiency	15/487	30/7206	1.36964514403e-10
ko05145	Toxoplasmosis	31/487	126/7206	1.39893841332e-10
ko05321	Inflammatory bowel disease (IBD)	20/487	56/7206	2.15387712397e-10
ko04620	Toll-like receptor signaling pathway	27/487	100/7206	2.32049469113e-10
ko05140	Leishmaniasis	23/487	75/7206	3.19375856758e-10
ko05332	Graft-versus-host disease	11/487	18/7206	2.48230559974e-09
ko04659	Th17 cell differentiation	26/487	106/7206	4.77606241543e-09
ko05330	Allograft rejection	12/487	24/7206	1.01736615295e-08
ko04612	Antigen processing and presentation	21/487	77/7206	1.9839202708e-08
ko05152	Tuberculosis	35/487	187/7206	2.30399858295e-08
ko05168	Herpes simplex infection	34/487	182/7206	3.8672554241e-08
ko04622	RIG-I-like receptor signaling pathway	18/487	62/7206	7.20624414273e-08
ko05150	Staphylococcus aureus infection	13/487	36/7206	2.86449967813e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	33/487	191/7206	4.18799026441e-07
ko04630	Jak-STAT signaling pathway	26/487	132/7206	5.51867162634e-07
ko04660	T cell receptor signaling pathway	25/487	124/7206	5.76848512765e-07
ko05320	Autoimmune thyroid disease	11/487	29/7206	1.36008613273e-06
ko04623	Cytosolic DNA-sensing pathway	13/487	41/7206	1.5960068097e-06
ko04672	Intestinal immune network for IgA production	12/487	37/7206	3.09079868689e-06
ko05133	Pertussis	19/487	87/7206	3.84591086852e-06
ko04940	Type I diabetes mellitus	11/487	32/7206	4.20985290967e-06
ko04658	Th1 and Th2 cell differentiation	20/487	96/7206	4.63411153148e-06
ko05323	Rheumatoid arthritis	19/487	89/7206	5.49230790385e-06
ko04062	Chemokine signaling pathway	31/487	201/7206	1.16253924805e-05
ko05142	Chagas disease (American trypanosomiasis)	23/487	130/7206	1.63491340554e-05
ko04640	Hematopoietic cell lineage	15/487	64/7206	1.64410633469e-05
ko05161	Hepatitis B	28/487	173/7206	1.64608948526e-05
ko00120	Primary bile acid biosynthesis	8/487	20/7206	2.50616671895e-05
ko05144	Malaria	12/487	45/7206	2.91475670617e-05
ko04668	TNF signaling pathway	21/487	120/7206	4.50206052647e-05
ko05310	Asthma	7/487	17/7206	6.60976253124e-05
ko04662	B cell receptor signaling pathway	17/487	88/7206	6.6503524576e-05
ko04210	Apoptosis	26/487	180/7206	0.000212968034575
ko04610	Complement and coagulation cascades	15/487	79/7206	0.00021659593616
ko05160	Hepatitis C	23/487	153/7206	0.000242378557602
ko04390	Hippo signaling pathway	2/487	188/7206	0.000324296614419
ko04310	Wnt signaling pathway	2/487	181/7206	0.000467735370953
ko05034	Alcoholism	4/487	238/7206	0.000517025028768
ko03040	Spliceosome	1/487	145/7206	0.00067914594367
ko04137	Mitophagy - animal	14/487	82/7206	0.00106397554283
ko04664	Fc epsilon RI signaling pathway	13/487	77/7206	0.00176620219728
ko04657	IL-17 signaling pathway	14/487	87/7206	0.00191822857842
ko04360	Axon guidance	5/487	233/7206	0.00205677183222
ko03010	Ribosome	1/487	129/7206	0.00215565526555
ko00590	Arachidonic acid metabolism	10/487	52/7206	0.00217653171168
ko04611	Platelet activation	22/487	163/7206	0.00218418288582
ko03050	Proteasome	10/487	54/7206	0.00291596704657
ko05132	Salmonella infection	15/487	98/7206	0.00324124875497
ko05146	Amoebiasis	15/487	99/7206	0.00341316223674
ko05134	Legionellosis	12/487	74/7206	0.0037034954629
ko04142	Lysosome	20/487	151/7206	0.00446094299731
ko04666	Fc gamma R-mediated phagocytosis	17/487	122/7206	0.00510568679586
ko00140	Steroid hormone biosynthesis	8/487	41/7206	0.00540148827168
ko04916	Melanogenesis	2/487	142/7206	0.00599595849307
ko00051	Fructose and mannose metabolism	8/487	42/7206	0.00628830722215
ko00592	alpha-Linolenic acid metabolism	5/487	19/7206	0.00726486713997
ko05418	Fluid shear stress and atherosclerosis	21/487	173/7206	0.00828358022323
ko04080	Neuroactive ligand-receptor interaction	16/487	423/7206	0.00928531788145
ko04530	Tight junction	6/487	228/7206	0.0100035796288
ko04145	Phagosome	20/487	162/7206	0.0100198987494
ko04723	Retrograde endocannabinoid signaling	4/487	175/7206	0.0136225605022
ko00980	Metabolism of xenobiotics by cytochrome P450	7/487	40/7206	0.0163790271193
ko04110	Cell cycle	3/487	145/7206	0.018146386219
ko05143	African trypanosomiasis	6/487	32/7206	0.0185680819889
ko05031	Amphetamine addiction	1/487	91/7206	0.0204271315134
ko04911	Insulin secretion	2/487	117/7206	0.0239733147319
ko05131	Shigellosis	11/487	82/7206	0.024478103551
ko04728	Dopaminergic synapse	5/487	185/7206	0.0246187050252
ko05416	Viral myocarditis	8/487	55/7206	0.0301897156387
ko04111	Cell cycle - yeast	1/487	90/7206	0.0308502754493
ko05169	Epstein-Barr virus infection	22/487	206/7206	0.0330304596854
ko01524	Platinum drug resistance	10/487	76/7206	0.0357370857709
ko00982	Drug metabolism - cytochrome P450	6/487	37/7206	0.0358857786949
ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2/487	5/7206	0.0397522647987
ko05204	Chemical carcinogenesis	7/487	48/7206	0.0407812358417
ko04068	FoxO signaling pathway	18/487	167/7206	0.042274645559
ko04721	Synaptic vesicle cycle	1/487	80/7206	0.0426790066127
ko05224	Breast cancer	5/487	174/7206	0.0446085455678
ko04020	Calcium signaling pathway	10/487	265/7206	0.0459982889639
ko04917	Prolactin signaling pathway	11/487	87/7206	0.0477793228192